How teen brain immune cells change dopamine receptors and affect opioid risk
Microglial pruning of dopamine receptors and opioid abuse.
Researchers are seeing whether immune cells in the adolescent brain change dopamine receptors in ways that raise the chance of later opioid problems, using animal models focused on male adolescence.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11292871 on NIH RePORTER |
What this research studies
This project uses animal experiments (mainly male rats) to look at how microglia, the brain's immune cells, remove dopamine D1 receptors in the nucleus accumbens during adolescence. The team will examine how tagging of those receptors by a complement protein (C3) leads to pruning and how adolescent morphine exposure changes microglial behavior. They will test whether altering dopamine signaling or using a glial-modulating drug during adolescence changes pruning and later addiction-like behaviors. The goal is to link specific developmental changes in the brain to increased opioid relapse risk in adulthood.
Who could benefit from this research
Good fit: The grant does not enroll people, but its findings would be most relevant to adolescent males who used or were exposed to opioids during their teenage years.
Not a fit: People not represented in the animal models—for example females or individuals whose opioid exposure began only in adulthood—may not directly benefit from these specific results.
Why it matters
Potential benefit: If successful, the work could point to ways to prevent or reduce long-term opioid addiction risk after teen exposure by targeting microglia or dopamine receptor changes.
How similar studies have performed: Prior preclinical studies in rats have shown microglial pruning of dopamine receptors and that adolescent opioid exposure alters microglial function, but translating these findings to human treatments remains unproven.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Bilbo, Staci D — Duke University
- Study coordinator: Bilbo, Staci D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.